[1]
E. Simpson, “Tralokinumab Monotherapy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Regional Differences in Baseline Disease Characteristics and Prior Treatment in the ECZTRA 1 and ECZTRA 2 Trials”, J of Skin, vol. 4, no. 6, p. s101, Oct. 2020.